Faculty mentor: Nicola Camp
Multiple myeloma (MM), a plasma cell cancer, is one of the more common hematological malignancies and is increasing 0.8%/yr. Treatments have improved but most patients do not survive 5 years. Notably, it has double the incidence in African Americans. A novel approach, introduced by the Camp lab, for modeling gene expression in tumors has been applied to MM tumor cells in hopes to one day understand molecular racial disparities, predict survival and response to treatment in MM patients.
Click below to hear me present my poster!
Click on the social media icons above to share this page.
Questions or comments? Contact me at: firstname.lastname@example.org